Scientists and doctors are constantly researching new ways to treat cancer more effectively and conveniently. Prostate cancer is a common type of cancer in men, affecting many every year.
A new study called the PACE B has discovered a promising way to treat men with a medium risk, localized form of prostate cancer, making treatment quicker and less stressful for patients.
This breakthrough was shared at the annual meeting of the American Society for Radiation Oncology (ASTRO).
Easier Treatment with Equal Effectiveness
The new method, called Stereotactic Body Radiation Therapy (SBRT), is as effective as the traditional radiation treatment but much quicker.
Normally, patients who choose radiation therapy for medium-risk prostate cancer undergo treatment in up to 40 daily doses over several weeks.
But SBRT requires fewer, more concentrated doses, meaning it can be completed in just five outpatient sessions.
This is not only more convenient for the patient, reducing the number of visits to the hospital, but it also allows hospitals and treatment centers to help more people in less time, making better use of their resources.
This new approach uses advanced technology to direct radiation more accurately, avoiding damage to healthy tissues around the tumor. The results of the study are quite promising.
In a comparison, SBRT showed a 96% success rate in controlling the disease over five years, almost the same as the 95% rate achieved by conventional radiation therapy.
Nicholas van As, MD, the lead researcher for the trial, highlighted the positive implications of this new method, emphasizing that it allows for low toxicity treatment in five days, with high chances of keeping the cancer under control.
More About the Study
The study, PACE B, involved 874 participants, with an average age of around 70, from 38 centers in the UK and Canada.
The participants were monitored for approximately six years to observe the long-term effects and success rates of the treatments.
Those who received SBRT had nearly the same success rate as those who received conventional treatment, proving SBRT is a viable alternative.
Both treatments had low side effects. At five years post-treatment, only a small percentage of patients in both groups experienced significant side effects. This is crucial, as it means this new, shorter treatment does not compromise patient safety or comfort.
Simplicity and Efficiency
Prostate cancer, if detected early, is usually found to be localized, meaning it hasn’t spread beyond the prostate gland.
Previously, the main options available for such cases were active surveillance, radiation therapy, or surgery to remove the prostate gland.
This new method offers another option, especially for those who might find the longer radiation therapy difficult due to time constraints or other reasons.
This new technique has significant implications for healthcare systems and patients alike, offering a more efficient and equally effective treatment option.
But it’s crucial to understand that this discovery mainly benefits men at a medium risk of prostate cancer, not those with higher-risk forms of the disease.
The researchers are clear that these results don’t apply to everyone and further studies are ongoing to explore the benefits of SBRT for patients with higher-risk diseases.
The Bigger Picture
This study is part of a series of PACE trials exploring the potential of SBRT for localized prostate cancer.
Other trials in the series are focusing on different aspects such as comparing SBRT to surgery and investigating how well SBRT works in combination with hormone therapy for patients with medium and high-risk prostate cancer.
This breakthrough means men with medium risk, localized prostate cancer now have another treatment option to consider, which is more convenient and just as effective as conventional methods.
For many, this could mean less time spent in hospitals, less stress, and more successful management of their condition, allowing them to maintain a better quality of life during treatment.
Conclusion
The discovery of SBRT as an effective and efficient treatment for medium-risk, localized prostate cancer is a beacon of hope for many.
It not only eases the treatment process for patients but also optimizes the resource utilization in hospitals and treatment centers.
However, it’s pivotal for patients to understand the applicability of this method and to discuss with their healthcare providers whether it’s the right choice based on their individual circumstances, especially considering it mainly benefits those at a medium risk.
Nonetheless, continued research in this area holds the promise of more groundbreaking discoveries that could potentially revolutionize prostate cancer treatment, benefiting patients and healthcare systems alike.
If you care about cancer, please read studies about low-carb diet could increase overall cancer risk and how drinking milk affects risks of heart disease and cancer.
If you care about prostate cancer, please read studies about 5 types of bacteria linked to aggressive prostate cancer, and new strategy to treat advanced prostate cancer.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
